82-98-4
Chemical Structure
Piperidolate
- CAS No.: 82-98-4
- Formula:C21H25NO2
- Molecular Weight:323.43
IUPAC Name: 1-ethylpiperidin-3-yl 2,2-diphenylacetate
InChIKey: KTHVBAZBLKXIHZ-UHFFFAOYSA-N
SMILES: O=C(OC1CN(CC)CCC1)C(C2=CC=CC=C2)C3=CC=CC=C3
Biological Activity: Piperidolate is a cholinergic antagonist. Piperidolate prevents ventricular fibrillation during hypothermic cardiac manipulations to support cardiac procedures post-preoperative defibrillation. Piperidolate causes dose-dependent cardiac depression. Piperidolate can be used for the research of ventricular fibrillation[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Piperidolate | 98.53% | Piperidolate is a cholinergic antagonist. Piperidolate prevents ventricular fibrillation during hypothermic cardiac manipulations to support cardiac procedures post-preoperative defibrillation. Piperidolate causes dose-dependent cardiac depression. Piperidolate can be used for the research of ventricular fibrillation. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Piperidolate (Standard) | ≥98% | Piperidolate (Standard) is the analytical standard of Piperidolate. This product is intended for research and analytical applications. Piperidolate is a cholinergic antagonist. Piperidolate prevents ventricular fibrillation during hypothermic cardiac manipulations to support cardiac procedures post-preoperative defibrillation. Piperidolate causes dose-dependent cardiac depression. Piperidolate can be used for the research of ventricular fibrillation. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. HARA M, et al. Antifibrillatory action of piperidolate hydrochloride (dactil) in hypothermia. AMA Arch Surg. 1957 Nov;75(5):780-4. [Content Brief]
- [2]. Ozawa H, et al. Effect of Piperidolate, which Has Antispasmodic Effects, on Removed Smooth Muscle, Especially Uterine Smooth Muscle Under Sex Hormone Influence (1). Japanese Journal of Pharmacology. 1974;70(5):659-671.
Keywords